+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report by Technology (Cell Culture, High Throughput), by Method, by Application, by End Use, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4582070
  • Report
  • February 2020
  • Region: Global
  • 100 pages
  • Grand View Research

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • BioIVT
  • Charles River
  • Cyprotex
  • GE Healthcare
  • InSphero
The global in-vitro toxicology testing market size is anticipated to reach USD 30.9 billion by 2027 and is projected to register a CAGR of 9.2% over the forecast period according to this report. The new paradigm shift in toxicity testing of animal models toward computational methods such as silico models to interpret toxicity pathway data, drives the demand for in-vitro toxicology testing. These methods provide cost and time efficiency and enhance safety assessment.

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity, absorption, distribution, metabolism, and excretion (ADME), pharmacovigilance, and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market.

Further key findings from the report suggest:
  • Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2019
  • Omics technology is anticipated to register lucrative growth as RNA sequencing and shotgun proteomics are increasingly used for a more comprehensive understanding of the effects of toxicants
  • The high usage rate of cellular assays with advancements in cell-based technologies, including label-free detection and high-content screening, has contributed to the dominance of the cellular assays segment in 2019
  • Systemic toxicology emerged as the leading application segment in 2019 as it plays a key role in risk assessment during drug development procedures. For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease
  • Pharmaceutical industry dominated the in-vitro toxicology testing market in 2019 as toxicological testing is a prerequisite step for drug development
  • Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models. Hence, North America dominated the global market in 2019
  • The Asia Pacific region is anticipated to witness the fastest growth rate over the forecast period due to increasing initiatives by public agencies to encourage acceptance of non-animal test models
  • Abbott, Thermo Fisher, Agilent Technologies, GE Healthcare, Bio-Rad, and Merck KGaA are some of the key players operating in the market.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • BioIVT
  • Charles River
  • Cyprotex
  • GE Healthcare
  • InSphero
Chapter 1 Executive Summary
1.1 Market Outlook
1.2 In-vitro Toxicology Testing Market: Segment Outlook
1.3 In-vitro Toxicology Testing Market: Competitive Insights

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Penetration & Growth Prospect Mapping For Application, 2019
3.3 In-vitro Toxicology Testing Market: Cost Structure Analysis
3.4 In-vitro Toxicology Testing Market: Technology Overview
3.5 In-vitro Toxicology Testing Market: Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Rise in government funding for toxicology research
3.5.1.2 Opposition to animal testing
3.5.1.3 Ongoing developments to advance toxicology research
3.5.2 Market restraint analysis
3.5.2.1 Lack of in-vitro models
3.5.2.2 Issues pertaining to standardization of in-vitro studies
3.6 In-vitro Toxicology Testing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.7 Industry Analysis - Porter’s

Chapter 4 Market Categorization: Technology Estimates & Trend Analysis
4.1 In-vitro toxicology testing Market: Technology Movement Analysis, 2019 & 2027
4.2 Cell Culture Technology
4.2.1 Global cell culture technology market, by revenue 2016 - 2027 (USD Million)
4.3 High-Throughput Technology (HTT)
4.3.1 Global high-throughput technology market, by revenue 2016 - 2027 (USD Million)
4.4 Molecular imaging
4.4.1 Global molecular imaging market, by revenue 2016 - 2027 (USD Million)
4.5 OMICS technology
4.5.1 Global OMICS technology market, by revenue 2016 - 2027 (USD Million)

Chapter 5 Market Categorization: Method Estimates & Trend Analysis
5.1 In-vitro toxicology testing Market: Method Movement Analysis
5.2 Cellular Assays
5.2.1 Global cellular assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
5.3 Biochemical Assays
5.3.1 Global biochemical assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
5.4 In Silico
5.4.1 Global in silico assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
5.5 Ex Vivo
5.5.1 Global ex vivo assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)

Chapter 6 Market Categorization: Application Estimates & Trend Analysis
6.1 In-vitro Toxicology Testing Market: Application Movement Analysis
6.2 Systemic Toxicology
6.2.1 Global systemic toxicology market, 2016 - 2027 (USD Million)
6.3 Dermal Toxicity
6.3.1 Global dermal toxicity market, 2016 - 2027 (USD Million)
6.4 Endocrine Disruption
6.4.1 Global endocrine disruption market, 2016 - 2027 (USD Million)
6.5 Ocular Toxicity
6.5.1 Global ocular toxicity market, 2016 - 2027 (USD Million)
6.6 Other Applications
6.6.1 Global other applications market, 2016 - 2027 (USD Million)

Chapter 7 Market Categorization: End-use Estimates & Trend Analysis
7.1 In-vitro Toxicology Testing Market: End-use Movement Analysis
7.2 Pharmaceutical Industry
7.2.1 Global pharmaceutical industry market, 2016 - 2027 (USD Million)
7.3 Cosmetics & Household Products
7.3.1 Global cosmetics & household products market, 2016 - 2027 (USD Million)
7.4 Diagnostics
7.4.1 Global diagnostics market, 2016 - 2027 (USD Million)
7.5 Chemical Industry
7.5.1 Global chemical industry market, 2016 - 2027 (USD Million)
7.6 Food Industry
7.6.1 Global food industry market, 2016 - 2027 (USD Million)

Chapter 8 Market Categorization: Regional Estimates & Trend Analysis, by End-use, Application, Method, & Technology
8.1 In-vitro Toxicology Testing Market Share By Region, 2019 & 2027
8.2 North America
8.2.1 North America in-vitro toxicology testing market, 2016 - 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.2.2.2 U.S. in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.2.2.3 U.S. in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.2.2.4 U.S. in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Canada in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.2.3.2 Canada in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.2.3.3 Canada in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.2.3.4 Canada in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.3 Europe
8.3.1 Europe in-vitro toxicology testing market, 2016 - 2027 (USD Million)
8.3.2 Germany
8.3.2.1 Germany in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.3.2.2 Germany in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.3.2.3 Germany in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.3.2.4 Germany in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.3.3.2 U.K. in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.3.3.3 U.K. in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.3.3.4 U.K. in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific in-vitro toxicology testing market, 2016 - 2027 (USD Million)
8.4.2 China
8.4.2.1 China in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.4.2.2 China in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.4.2.3 China in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.4.2.4 China in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.4.3 Japan
8.4.3.1 Japan in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.4.3.2 Japan in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.4.3.3 Japan in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.4.3.4 Japan in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America in-vitro toxicology testing market, 2016 - 2027 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.5.2.2 Brazil in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.5.2.3 Brazil in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.5.2.4 Brazil in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa in-vitro toxicology testing market, 2016 - 2027 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
8.6.2.2 South Africa in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
8.6.2.3 South Africa in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
8.6.2.4 South Africa in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)

Chapter 9 Competitive Landscape
9.1 Market Participation Categorization
9.2 Recent Developments & Impact Analysis, by Key Market Participants
9.3 Public Companies
9.3.1 Company market position analysis
9.4 Private Companies
9.4.1 List of key emerging companies/ innovators
9.5 Strategy Framework
9.6 Company Profiles
9.6.1 Agilent Technologies
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product Benchmarking
9.6.1.4 Strategic initiatives
9.6.2 Abbott
9.6.2.1 Company overview
9.6.2.1.1 Alere Inc.
9.6.2.2 Financial performance
9.6.2.2.1 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 Bio-Rad Laboratories, Inc.
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic initiatives
9.6.4 Merck KGaA
9.6.4.1 Company overview
9.6.4.1.1 BioReliance Corporation
9.6.4.1.2 Sigma Aldrich, Inc.
9.6.4.2 Financial performance
9.6.4.2.1 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic initiatives
9.6.5 Charles River
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic initiatives
9.6.6 Thermo Fisher Scientific Inc.
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic initiatives
9.6.7 Catalent, Inc.
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 Eurofins Scientific
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 GE Healthcare
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Quest Diagnostics Incorporated
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Laboratory Corporation of America Holdings
9.6.11.1 Company overview
9.6.11.1.1 Covance Inc.,
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.12 Evotec
9.6.12.1 Company overview
9.6.12.1.1 Cyprotex
9.6.12.2 Financial performance
9.6.12.3 Product benchmarking
9.6.12.4 Strategic initiatives
9.6.13 Creative Bioarray
9.6.13.1 Company overview
9.6.13.2 Financial performance
9.6.13.3 Product benchmarking
9.6.13.4 Strategic initiatives
9.6.14 Gentronix
9.6.14.1 Company overview
9.6.14.2 Financial performance
9.6.14.3 Product benchmarking
9.6.14.4 Strategic initiatives
9.6.15 HD Biosciences Co., Ltd.
9.6.15.1 Company overview
9.6.15.2 Financial performance
9.6.15.3 Product benchmarking
9.6.15.4 Strategic initiatives
9.6.16 MB Research Laboratories
9.6.16.1 Company overview
9.6.16.2 Financial performance
9.6.16.3 Product benchmarking
9.6.16.4 Strategic initiatives
9.6.17 BioIVT
9.6.17.1 Company overview
9.6.17.2 Financial performance
9.6.17.3 Product benchmarking
9.6.17.4 Strategic initiatives
9.6.18 SGS SA
9.6.18.1 Company overview
9.6.18.2 Financial performance
9.6.18.3 Product benchmarking
9.6.18.4 Strategic initiatives
9.6.19 GVK Biosciences Private Limited
9.6.19.1 Company overview
9.6.19.2 Financial performance
9.6.19.3 Product benchmarking
9.6.19.4 Strategic initiatives
9.6.20 InSphero
9.6.20.1 Company overview
9.6.20.2 Financial performance
9.6.20.3 Product benchmarking
9.6.20.4 Strategic initiatives
Note: Product cover images may vary from those shown
  • Agilent Technologies
  • Abbott
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • BioReliance Corporation
  • Sigma Aldrich, Inc.
  • Charles River
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Eurofins Scientific
  • GE Healthcare
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Covance Inc.,
  • Evotec
  • Cyprotex
  • Creative Bioarray
  • Gentronix
  • HD Biosciences Co., Ltd.
  • MB Research Laboratories
  • BioIVT
  • SGS SA
  • GVK Biosciences Private Limited
  • InSphero
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll